THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Smart drug for lung cancer may be pulled from market

Iressa helps small portion of patients

By Raja Mishra
Globe Staff / April 5, 2005

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Two years ago, enormous fanfare greeted the drug, Iressa, which zipped through the government approval process to become the first so-called smart drug for lung cancer patients. Such drugs home in on tumors, in contrast to many chemotherapies and radiation treatments that destroy healthy cells along with cancerous ones, often causing debilitating side effects. (Full article: 1203 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass

Connect with Boston.com

Twitter Follow us on @BostonUpdate, other Twitter accounts